Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma. [PDF]
Zhang Z +9 more
europepmc +1 more source
Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147<sup>+</sup> extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma. [PDF]
Qian L +13 more
europepmc +1 more source
TMEM166 negatively regulates unfolded protein response to affect hepatocellular carcinoma cell growth and sorafenib resistance. [PDF]
Li T +7 more
europepmc +1 more source
Commentary: Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. [PDF]
Chen X +5 more
europepmc +1 more source
Emerging trends and knowledge networks in pan-cancer sorafenib resistance: a 20-year bibliometric investigation. [PDF]
Zhou Q, Wang R.
europepmc +1 more source
PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. [PDF]
Guo M +9 more
europepmc +1 more source
Neuropilin-2 (NRP2) mediates sorafenib resistance in clear cell renal cell carcinoma via the NRP2/NF-κB/TNFα axis. [PDF]
Gu R +8 more
europepmc +1 more source
Silencing progestagen-associated endometrial protein (PAEP) suppresses sorafenib resistance and enhances sorafenib-induced ferroptosis in hepatocellular carcinoma. [PDF]
Zeng F +9 more
europepmc +1 more source
A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3η-modified tumor-associated proteome. [PDF]
Jin M +15 more
europepmc +1 more source
MYB Confers Sorafenib Resistance in Human Leukemia Cells via Inhibiting Ferroptosis Through FTH1 Upregulation. [PDF]
Tao X +6 more
europepmc +1 more source

